Peptidoliposomes containing different combinations of the CCR5 (N-terminus and ECL2) and CD4-peptidomimetics were initially tested for their ability to inhibit infection of TZM-HeLa-β-gal target cells by R5-tropic JRFL-pseudotyped HIV-1. Here, CD4 is linked to infection.